Narasaki Yoko, You Amy S, Kurtz Ira, Nobakht Niloofar, Kamgar Mohammad, Siu Man Kit Michael, Ahdoot Rebecca S, Hanna Ramy, Kalantar Sara S, Yoon Jihoon, Le Lisa, Torres Rivera Silvina, Nakata Tracy, Arora Ria, Nguyen Danh V, Kalantar-Zadeh Kamyar, Rhee Connie M
Division of Nephrology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA.
Nephrology Division, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA.
Kidney Med. 2025 Feb 11;7(4):100976. doi: 10.1016/j.xkme.2025.100976. eCollection 2025 Apr.
RATIONALE & OBJECTIVE: While sleep disorders are common in patients treated with hemodialysis, the impact of sleep patterns on survival is not well defined. We thus examined the association of specific sleep patterns with mortality in this population.
An observational cohort study.
SETTING & POPULATION: In-center hemodialysis patients from the multicenter prospective NIH Malnutrition, Diet, and Racial Disparities in Chronic Kidney Disease (MADRAD) cohort.
Sleep patterns ascertained using protocolized sleep surveys from March 2014 to June 2019.
Mortality.
Cox proportional hazards models.
Among 452 participants, the mean age was 55±14 years, among whom 46% were women and the median follow-up was 3.5 years. In expanded case-mix models, shorter sleep duration (≤ median of observed values) was associated with higher mortality on dialysis and nondialysis days (ref: > median): HRs (95% CIs) 1.59 (1.09-2.31) and 1.51 (1.04-2.19), respectively. Patients who reported high frequencies (often/almost always) of difficulty falling asleep, feeling unrested, fatigue/exhaustion post-dialysis, or fatigue/exhaustion on nondialysis days had higher mortality (ref: never/rarely having these symptoms): HRs (95% CIs) 1.74 (1.17-2.58), 1.69 (1.1-2.5), 2.42 (1.41-4.16), and 1.73 (1.11-2.69), respectively. Moderate to high frequency of sleeping pill use was associated with higher mortality (ref: never/rare use): HRs (95% CIs) 2.07 (1.08, 3.97) and 2.00 (1.22, 3.28) for sometimes and often/almost always using sleeping pills, respectively. Sleeping outside of the primary sleep period (intra-dialytic sleeping and napping) was not associated with worse survival. However, patients reporting frequent apnea or restless legs syndrome had higher mortality.
Potential recall bias, residual confounding, absence of time-varying observations, and limitations in generalizability.
In a well-characterized prospective multicenter hemodialysis cohort, patients who reported shorter sleep duration, sleeping difficulty or feeling unrested, moderate to frequent sleeping pill consumption, and sleep disorders (apnea and restless legs) had a higher mortality risk.
虽然睡眠障碍在接受血液透析治疗的患者中很常见,但睡眠模式对生存率的影响尚不明确。因此,我们研究了该人群中特定睡眠模式与死亡率之间的关联。
一项观察性队列研究。
来自多中心前瞻性美国国立卫生研究院慢性肾脏病营养不良、饮食和种族差异(MADRAD)队列的中心血液透析患者。
通过2014年3月至2019年6月的标准化睡眠调查确定睡眠模式。
死亡率。
Cox比例风险模型。
在452名参与者中,平均年龄为55±14岁,其中46%为女性,中位随访时间为3.5年。在扩展的病例组合模型中,较短的睡眠时间(≤观察值中位数)与透析日和非透析日的较高死亡率相关(参照:>中位数):风险比(95%置信区间)分别为1.59(1.09 - 2.31)和1.51(1.04 - 2.19)。报告入睡困难、感觉未休息好、透析后疲劳/疲惫或非透析日疲劳/疲惫频率较高(经常/几乎总是)的患者死亡率较高(参照:从不/很少有这些症状):风险比(95%置信区间)分别为1.74(1.17 - 2.58)、1.69(1.1 - 2.5)、2.42(1.41 - 4.16)和1.73(1.11 - 2.69)。中度至高频使用安眠药与较高死亡率相关(参照:从不/很少使用):有时和经常/几乎总是使用安眠药的风险比(95%置信区间)分别为2.07(1.08,3.97)和2.00(1.22,3.28)。在主要睡眠时间之外睡眠(透析期间睡眠和小睡)与较差的生存率无关。然而,报告频繁呼吸暂停或不安腿综合征的患者死亡率较高。
存在潜在的回忆偏倚、残余混杂、缺乏随时间变化的观察以及普遍性方面的局限性。
在一个特征明确的前瞻性多中心血液透析队列中,报告睡眠时间较短、入睡困难或感觉未休息好、中度至频繁使用安眠药以及存在睡眠障碍(呼吸暂停和不安腿)的患者死亡风险较高。